Related references
Note: Only part of the references are listed.Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders
Nader H. Moniri
BIOCHEMICAL PHARMACOLOGY (2016)
Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes
Zheng Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Discovery of the imidazole-derived GPR40 agonist AM-3189
Zhihua Ma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Design, synthesis and Structure-activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes
Zheng Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent models
Dan-yang Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Synthesis and biological evaluation of phenoxyacetic acid derivatives as novel free fatty acid receptor 1 agonists
Xuekun Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Design, synthesis and structure-activity relationship studies of novel phenoxyacetamide-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes
Zheng Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Design, synthesis and biological activity of phenoxyacetic acid derivatives as novel free fatty acid receptor 1 agonists
Zheng Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Optimization of 3-aryl-3-ethoxypropanoic acids and discovery of the potent GPR40 agonist DS-1558
Rieko Takano et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Safety of antidiabetes medications: An update
C. J. Bailey
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Intestinal nutrient sensing and blood glucose control
Tamara Zietek et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2015)
Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial
K. Kaku et al.
DIABETES OBESITY & METABOLISM (2015)
Medications for type 2 diabetes: how will we be treating patients in 50 years?
Steven E. Kahn et al.
DIABETOLOGIA (2015)
Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
Andre J. Scheen
EXPERT OPINION ON DRUG SAFETY (2015)
Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research
Ang Li et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Discovery of novel FFA4 (GPR120) receptor agonists with β-arrestin2-biased characteristics
Ang Li et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes
Cong Tang et al.
NATURE MEDICINE (2015)
Dual effects of the non-esterified fatty acid receptor 'GPR40' for human health
Tetsumori Yamashima
PROGRESS IN LIPID RESEARCH (2015)
Discovery of a series of 2-(pyridinyl)pyrimidines as potent antagonists of GPR40
Michael J. Waring et al.
MEDCHEMCOMM (2015)
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
Rieko Takano et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Molecular Property Design: Does Everyone Get It?
Paul D. Leeson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Thoughts on the progression of type 2 diabetes drug discovery
Harikrashna B. Bhatt
EXPERT OPINION ON DRUG DISCOVERY (2015)
Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury
Xiuli Li et al.
DRUG METABOLISM AND DISPOSITION (2015)
Omega-3 Fatty Acids and Other FFA4 Agonists Inhibit Growth Factor Signaling in Human Prostate Cancer Cells
Ze Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists
Rieko Takano et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120)
Steven M. Sparks et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus
Elisabeth Defossa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function
Mahesh Kumar Verma et al.
BMC CELL BIOLOGY (2014)
Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists
Ryutaro Nakashima et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Novel approaches to drug discovery for the treatment of type 2 diabetes
Xing Xu et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Discontinued in 2013: diabetic drugs
Maka S. Hedrington et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
The fish oil ingredient, docosahexaenoic acid, activates cytosolic phospholipase A2 via GPR120 receptor to produce prostaglandin E2 and plays an anti-inflammatory role in macrophages
Yueqin Liu et al.
IMMUNOLOGY (2014)
The Molecular Basis of Ligand Interaction at Free Fatty Acid Receptor 4 (FFA4/GPR120)
Brian D. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion
Hirotsugu Tanaka et al.
LIFE SCIENCES (2014)
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875
Ankita Srivastava et al.
NATURE (2014)
A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice
Da Young Oh et al.
NATURE MEDICINE (2014)
KDT501, a Derivative from Hops, Normalizes Glucose Metabolism and Body Weight in Rodent Models of Diabetes
Veera R. Konda et al.
PLOS ONE (2014)
Regulation of energy metabolism by long-chain fatty acids
Manabu T. Nakamura et al.
PROGRESS IN LIPID RESEARCH (2014)
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists
Xiaohui Du et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Optimization of GPR40 Agonists for Type 2 Diabetes
Jiwen (Jim) Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients
Venkategowda Sunil et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Discovery of novel orally bioavailable GPR40 agonists
Hejun Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats
R. Ito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Free Fatty Acids-Sensing G Protein-Coupled Receptors in Drug Targeting and Therapeutics
Tomo Yonezawa et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes
Kohei Kaku et al.
DIABETES CARE (2013)
Modulating GPR40: therapeutic promise and potential in diabetes
Vincent Poitout et al.
DRUG DISCOVERY TODAY (2013)
A review of the efficacy and safety of oral antidiabetic drugs
Stephanie Aleskow Stein et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Discovery of a Potent and Selective Free Fatty Acid Receptor 1 Agonist with Low Lipophilicity and High Oral Bioavailability
Elisabeth Christiansen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma
Q. Wu et al.
ONCOGENE (2013)
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
Chiori Yabuki et al.
PLOS ONE (2013)
GPR43/FFA2: physiopathological relevance and therapeutic prospects
Laure B. Bindels et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes
Elisabeth Christiansen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles
Yingcai Wang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats
Nagesh Gowda et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism
Brian D. Hudson et al.
MOLECULAR PHARMACOLOGY (2013)
Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
Hirotsugu Tanaka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Christopher A. Lipinski et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
AMG 837: A potent, orally bioavailable GPR40 agonist
Jonathan B. Houze et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
A Multiple-Ascending-Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK-875, in Subjects With Type 2 Diabetes
E. Leifke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK-875: Results From a Double-Blind, Placebo-Controlled Single Oral Dose Rising Study in Healthy Volunteers
Himanshu Naik et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivity
Celine Martin et al.
JOURNAL OF LIPID RESEARCH (2012)
Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes
Satoshi Mikami et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of Fused-Ring Alkanoic Acids with Improved Pharmacokinetic Profiles that Act as G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonists
Nobuyuki Negoro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery of a Potent and Selective GPR120 Agonist
Bharat Shimpukade et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Optimization of (2,3-Dihydro-1-benzofuran-3-yl)acetic Acids: Discovery of a Non-Free Fatty Acid-Like, Highly Bioavailable G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist as a Glucose-Dependent Insulinotropic Agent
Nobuyuki Negoro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
Charles F. Burant et al.
LANCET (2012)
A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents
Jian Luo et al.
PLOS ONE (2012)
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist
Sean P. Brown et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Identification and Pharmacological Characterization of Multiple Allosteric Binding Sites on the Free Fatty Acid 1 Receptor
Daniel C. -H. Lin et al.
MOLECULAR PHARMACOLOGY (2012)
3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonists
Shawn P. Walsh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Identification of a Potent and Selective Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist with Favorable Physicochemical and in Vitro ADME Properties
Elisabeth Christiansen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Design, Synthesis, and Biological Activity of Potent and Orally Available G Protein-Coupled Receptor 40 Agonists
Shinobu Sasaki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Management of type 2 diabetes: new and future developments in treatment
Abd A. Tahrani et al.
LANCET (2011)
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants
Goodarz Danaei et al.
LANCET (2011)
Type 2 diabetes mellitus-current therapies and the emergence of surgical options
Harold E. Lebovitz
NATURE REVIEWS ENDOCRINOLOGY (2011)
AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents
Daniel C. -H. Lin et al.
PLOS ONE (2011)
TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats
Yoshiyuki Tsujihata et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonists
Changyou Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
Da Young Oh et al.
CELL (2010)
Lipophilicity in drug discovery
Michael J. Waring
EXPERT OPINION ON DRUG DISCOVERY (2010)
Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
Olivia J. Phung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist
Nobuyuki Negoro et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Overexpression of GPR40 in Pancreatic β-Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic Mice
Kae Nagasumi et al.
DIABETES (2009)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
Molecular Pharmacology of Promiscuous Seven Transmembrane Receptors Sensing Organic Nutrients
Petrine Wellendorph et al.
MOLECULAR PHARMACOLOGY (2009)
The influence of lead discovery strategies on the properties of drug candidates
Gyoergy M. Keserue et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The long-chain fatty acid receptor, GPR40, and glucolipotoxicity: investigations using GPR40-knockout mice
Ruth Brownlie et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Type 2 Diabetes and Oral Antihyperglycemic Drugs
Mitchell Avery et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice
Carina P. Tan et al.
DIABETES (2008)
Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion
Sara Edfalk et al.
DIABETES (2008)
Metabolic activation of carboxylic acids
Christian Skonberg et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA1/GPR40), a Potential Target for the Treatment of Type II Diabetes
Elisabeth Christiansen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Identification of G protein-coupled receptor 120-selective agonists derived from PPARγ agonists
Takayoshi Suzuki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells
Toshiki Tanaka et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1,-2, and-3: Pharmacology and Pathophysiological Functions
Leigh A. Stoddart et al.
PHARMACOLOGICAL REVIEWS (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor
Stephen C. McKeown et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The regulation of adipogenesis through GPR120
Chizu Gotoh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from β-cells through activation of GPR40
Susanne Schnell et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Fatty acid signaling in the β-cell and insulin secretion
Christopher J. Nolan et al.
DIABETES (2006)
Synthesis and activity of small molecule GPR40 agonists
DM Garrido et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet β-cells:: mediation by PLC and L-type Ca2+ channel and link to insulin release
K Fujiwara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Role of GPR40 in fatty acid action on the β cell line INS-1E
H Shapiro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse
R Steneberg et al.
CELL METABOLISM (2005)
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
A Hirasawa et al.
NATURE MEDICINE (2005)
Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation
E Le Poul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids
CP Briscoe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids
AJ Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Y Itoh et al.
NATURE (2003)
Pleiotropic effects of fatty acids on pancreatic beta-cells
EP Haber et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Insulin signalling and the regulation of glucose and lipid metabolism
AR Saltiel et al.
NATURE (2001)
Share Paper
